Accelerated Approval: Adcomm Should Always Precede Withdrawal Proposal, US FDA Says

 
• By Sue Sutter
  
Skipping rope
The FDA does not want its centers to skip an advisory committee meeting when proposing to withdraw an accelerated approval product. (Shutterstock)

More from Review Pathways

More from Pathways & Standards